BRANDES INVESTMENT PARTNERS, LP - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
BRANDES INVESTMENT PARTNERS, LP ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$14,922,352
-29.8%
1,448,772
+12.4%
0.29%
-32.0%
Q2 2023$21,245,933
+60.6%
1,289,195
-10.8%
0.43%
+52.3%
Q1 2023$13,232,856
+11.7%
1,444,635
-12.7%
0.28%
-15.4%
Q4 2022$11,851,661
-12.4%
1,655,260
-38.7%
0.33%
-6.2%
Q3 2022$13,526,000
+52.6%
2,699,795
-25.7%
0.35%
+63.9%
Q2 2022$8,862,000
-56.6%
3,631,475
+21.5%
0.22%
-50.6%
Q1 2022$20,413,000
-2.8%
2,988,675
+15.0%
0.44%
-4.6%
Q4 2021$21,006,000
-34.0%
2,599,634
-19.9%
0.46%
-33.7%
Q3 2021$31,824,000
+45.9%
3,247,286
+0.2%
0.69%
+42.5%
Q2 2021$21,806,000
-16.2%
3,240,011
+10.4%
0.48%
-21.3%
Q1 2021$26,027,000
+31.3%
2,934,241
-0.9%
0.62%
+20.8%
Q4 2020$19,815,000
+38.4%
2,961,878
+4.3%
0.51%
+3.0%
Q3 2020$14,317,000
+19.4%
2,840,669
+91.5%
0.50%
+35.6%
Q2 2020$11,988,000
-7.9%
1,483,627
-9.5%
0.36%
-19.8%
Q1 2020$13,012,000
-52.8%
1,638,838
-55.1%
0.46%
-30.6%
Q4 2019$27,571,000
+7.2%
3,651,948
-40.9%
0.66%
-1.4%
Q3 2019$25,721,000
+31.2%
6,182,836
-8.9%
0.66%
+52.2%
Q2 2019$19,608,000
+93.0%
6,784,790
-3.8%
0.44%
+85.2%
Q1 2019$10,157,000
-44.7%
7,052,720
-0.9%
0.24%
-49.6%
Q4 2018$18,367,000
-34.0%
7,119,054
+12.4%
0.47%
-25.5%
Q3 2018$27,813,000
-8.7%
6,335,548
+27.5%
0.63%
-8.6%
Q2 2018$30,467,000
-13.1%
4,970,106
+3.4%
0.69%
-8.2%
Q1 2018$35,054,000
+29.2%
4,808,493
+45.3%
0.75%
+36.5%
Q4 2017$27,128,0003,308,2500.55%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders